The largest database of trusted experimental protocols

Naive t cell isolation kit

Manufactured by STEMCELL
Sourced in Canada

The Naive T cell isolation kit is a laboratory tool used to purify naive T cells from a sample. It utilizes a combination of magnetic beads and antibodies to selectively isolate the desired cell population.

Automatically generated - may contain errors

4 protocols using naive t cell isolation kit

1

Isolation and Differentiation of Murine T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4 T cells were isolated from spleen and lymph nodes by magnetic bead depletion using a CD4 T cell isolation kit (Miltenyi Biotec). Naive T cells were further isolated using naive T cell isolation kit (StemCell Technologies) or phycoerythrin (PE)-conjugated antibodies against CD25 and CD44, followed by PE magnetic bead depletion (Miltenyi Biotec). Freshly isolated naive T cells were differentiated into different T cell subsets with plate-bound αCD3 (5 µg/ml; 145-2C11) and soluble αCD28 (2 µg/ml; PV-1) in the presence of appropriate cytokines (Th0: 20 U/ml rhIL-2, 5 µg/ml αIFN-γ antibody, and 5 µg/ml αIL-4 antibody; Th1: 10 ng/ml rmIL-12 and 5 µg/ml αIL-4 antibody; Th2: 10ng/ml rmIL-4 and 5 µg/ml αIFN-γ antibody; Th17: 20 ng/ml rmIL-6, 2.5 ng/ml rhTGFβ1, 5 µg/ml αIFN-γ antibody, and 5 µg/ml αIL-4 antibody; T reg cells: 20 U/ml rhIL-2 and 5 ng/ml rhTGFβ1). All cytokines were purchased from PeproTech unless otherwise stated. For some Th17 differentiation experiments, TGF-β1, Nicotinamide (Sigma-Aldrich), or Ex-527 (Tocris) was added as indicated in the corresponding figures.
+ Open protocol
+ Expand
2

Isolation of Naive CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naive CD4+ T cells were isolated magnetically using a naive T cell isolation kit (Stemcell Technologies) according to the manufacturer's recommended protocol.
+ Open protocol
+ Expand
3

Generation and Expansion of CAR T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CAR T cells were produced using our research-grade protocol(25 (link)) for indicated experiments. Briefly, peripheral blood mononuclear cells (PBMCs) from healthy donors were obtained from the Michael Amini Transfusion Medicine Center at COH (IRB: 15283). CD8 and/or CD8 T naïve cells were isolated from PBMCs with Human Naïve CD8+ or Naive T Cell Isolation Kits, respectively (Stemcell Technologies, Vancouver, Canada). T cells were cultured in vivo-15 (Lonza, Basel, Switzerland) supplemented with 10% human serum (Valley biomedical, Winchester, Virginia, USA) and 100U/mL human IL-2, and activated with Human T-Activator CD3/CD28 beads (Life Technologies, Carlsbad, California, USA) for 24 hours before transduction with lentivirus at MOI 1. Cultures were maintained at 0.5–1×106 cells/mL in medium containing 100 U/mL IL-2. After 7 days, CD3/CD28 beads were removed by Dynamag-2. GFP-positive single CAR T cells or EGFR-positive dual CAR T cells were enriched by FACS, activated and expanded with CD3/CD28 bead stimulation for another 7 days. CD3/CD28 beads were removed by Dynamag-2 before use. T cells from each donor were used to produce un-transduced T-cell controls (mock) in parallel to CAR T cells.
+ Open protocol
+ Expand
4

Generation and Expansion of CAR T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CAR T cells were produced using our research-grade protocol(25 (link)) for indicated experiments. Briefly, peripheral blood mononuclear cells (PBMCs) from healthy donors were obtained from the Michael Amini Transfusion Medicine Center at COH (IRB: 15283). CD8 and/or CD8 T naïve cells were isolated from PBMCs with Human Naïve CD8+ or Naive T Cell Isolation Kits, respectively (Stemcell Technologies, Vancouver, Canada). T cells were cultured in vivo-15 (Lonza, Basel, Switzerland) supplemented with 10% human serum (Valley biomedical, Winchester, Virginia, USA) and 100U/mL human IL-2, and activated with Human T-Activator CD3/CD28 beads (Life Technologies, Carlsbad, California, USA) for 24 hours before transduction with lentivirus at MOI 1. Cultures were maintained at 0.5–1×106 cells/mL in medium containing 100 U/mL IL-2. After 7 days, CD3/CD28 beads were removed by Dynamag-2. GFP-positive single CAR T cells or EGFR-positive dual CAR T cells were enriched by FACS, activated and expanded with CD3/CD28 bead stimulation for another 7 days. CD3/CD28 beads were removed by Dynamag-2 before use. T cells from each donor were used to produce un-transduced T-cell controls (mock) in parallel to CAR T cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!